KALV - Kalvista Pharmaceuticals - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

178.1M

Cash

171.7M

Avg Qtr Burn

-19.85M

Short % of Float

10.58%

Insider Ownership

0.88%

Institutional Own.

Qtr Updated

01/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Sebetralstat (KVD900) (film coated) Details Hereditary angioedema , Rare diseases, Rare genetic disease Big Mover™ Suspected Mover™ Susp. Mover™	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KVD001 (IVT) Details DME (Diabetic Macular Edema)	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KVD824 (plasma kallikrein enzyme inhibitor) Details Hereditary angioedema , Rare diseases, Rare genetic disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.